CompletedNCT02566057
Pharmacogenetic Testing to Guide Treatment in Early Psychosis
About this title
Read the official source — NCT02566057Interventional studyAges 15–64United StatesSchizophrenia
Understand this study
Who was this study for?
Listed age limits: 15 years to 64 years.
- Listed locations
- Glen OaksSee all locations and recruitment
Study information
Study start dateStarted: July 10, 2014
- Recruitment status
- Completed
- Enrollment listed in the registry
- 36
- Sponsor
- Northwell Health
- Sponsor type
- Unknown or unclear
- Study type
- Biological
- Intervention type
- Biological
- Locations
- United States
- Age range
- From 15 Years to 64 Years
- Official registry ID
- NCT02566057
- Official title
Show the full official title
Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Glen Oaks
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Northwell Health.
Who was this study for?
Listed age limits: 15 years to 64 years.
